[
  {
    "ts": null,
    "headline": "Earnings live: Keurig Dr. Pepper stock pops, Waste Management and Whirlpool slip with Big Tech results on deck",
    "summary": "Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finnhub.io/api/news?id=77ec2bb4cd8375cdc88c8e8c31c6faa741da4e3fc27cbf3b7ec5128ffc89b1fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761598283,
      "headline": "Earnings live: Keurig Dr. Pepper stock pops, Waste Management and Whirlpool slip with Big Tech results on deck",
      "id": 137235229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
      "url": "https://finnhub.io/api/news?id=77ec2bb4cd8375cdc88c8e8c31c6faa741da4e3fc27cbf3b7ec5128ffc89b1fd"
    }
  },
  {
    "ts": null,
    "headline": "3 Dividend-Paying Drug Stocks to Buy at a Discount",
    "summary": "Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?",
    "url": "https://finnhub.io/api/news?id=8279545e1f4f5bdecd28252969f8e5e1a2b2d7c97b2bd40da73ad2885e5d5e61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761588000,
      "headline": "3 Dividend-Paying Drug Stocks to Buy at a Discount",
      "id": 137231008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?",
      "url": "https://finnhub.io/api/news?id=8279545e1f4f5bdecd28252969f8e5e1a2b2d7c97b2bd40da73ad2885e5d5e61"
    }
  },
  {
    "ts": null,
    "headline": "Are You Looking for a High-Growth Dividend Stock?",
    "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.",
    "url": "https://finnhub.io/api/news?id=139daa553b8f4b77b163d4249306c23bda6e85aa861fb6ad06226d0281fd0376",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761579902,
      "headline": "Are You Looking for a High-Growth Dividend Stock?",
      "id": 137231010,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=139daa553b8f4b77b163d4249306c23bda6e85aa861fb6ad06226d0281fd0376"
    }
  },
  {
    "ts": null,
    "headline": "Dr. Reddy's Q2 Earnings Beat Estimates, Generics Sales Boost Revenues",
    "summary": "RDY posts a Q2 earnings and revenue beat as global generics drive growth, while new launches and biosimilar advances shape its pipeline.",
    "url": "https://finnhub.io/api/news?id=a496a015c8fa8238313f310ff0c5a711f032d7c77cbe78e74e1430a0b90cdb65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761579120,
      "headline": "Dr. Reddy's Q2 Earnings Beat Estimates, Generics Sales Boost Revenues",
      "id": 137231011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RDY posts a Q2 earnings and revenue beat as global generics drive growth, while new launches and biosimilar advances shape its pipeline.",
      "url": "https://finnhub.io/api/news?id=a496a015c8fa8238313f310ff0c5a711f032d7c77cbe78e74e1430a0b90cdb65"
    }
  },
  {
    "ts": null,
    "headline": "What's in Store for These 5 Pharma Bigwigs This Earnings Season?",
    "summary": "As earnings season accelerates, pharma heavyweights LLY, MRK, ABBV, BMY and GILD prepare to reveal their Q3 results amid a strong sector start.",
    "url": "https://finnhub.io/api/news?id=057f3ad06e55bc44adb41ef797b5ff64f324132986bd4b6e788158e89c3b0d3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761577500,
      "headline": "What's in Store for These 5 Pharma Bigwigs This Earnings Season?",
      "id": 137230292,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "As earnings season accelerates, pharma heavyweights LLY, MRK, ABBV, BMY and GILD prepare to reveal their Q3 results amid a strong sector start.",
      "url": "https://finnhub.io/api/news?id=057f3ad06e55bc44adb41ef797b5ff64f324132986bd4b6e788158e89c3b0d3c"
    }
  },
  {
    "ts": null,
    "headline": "3 Healthcare Stocks to Buy Hand Over Fist in October",
    "summary": "One growth stock, one high-yield stock, and one Dividend King -- you should find something you like here as October draws to a close.",
    "url": "https://finnhub.io/api/news?id=f8e244215c856507ca6bea0adfcfb484fb6fd9b004a97265e91fc874fd9998a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761576300,
      "headline": "3 Healthcare Stocks to Buy Hand Over Fist in October",
      "id": 137228557,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "One growth stock, one high-yield stock, and one Dividend King -- you should find something you like here as October draws to a close.",
      "url": "https://finnhub.io/api/news?id=f8e244215c856507ca6bea0adfcfb484fb6fd9b004a97265e91fc874fd9998a8"
    }
  },
  {
    "ts": null,
    "headline": "JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?",
    "summary": "J&J's diversified growth, strong pipeline, and robust balance sheet position it as a steadier long-term pick over Merck's Keytruda-dependent outlook.",
    "url": "https://finnhub.io/api/news?id=5be54768e509d0d0d1c8d7d2b87be11df2dd3ab12c9cb4c23e2c170d574a4faa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761571140,
      "headline": "JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?",
      "id": 137228559,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "J&J's diversified growth, strong pipeline, and robust balance sheet position it as a steadier long-term pick over Merck's Keytruda-dependent outlook.",
      "url": "https://finnhub.io/api/news?id=5be54768e509d0d0d1c8d7d2b87be11df2dd3ab12c9cb4c23e2c170d574a4faa"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates",
    "summary": "Get a deeper insight into the potential performance of Merck (MRK) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "url": "https://finnhub.io/api/news?id=610ea16f656d045a7231595dc854fa666ab736f4f23dbc44372223de17111c7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761570905,
      "headline": "Merck (MRK) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates",
      "id": 137228661,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Get a deeper insight into the potential performance of Merck (MRK) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
      "url": "https://finnhub.io/api/news?id=610ea16f656d045a7231595dc854fa666ab736f4f23dbc44372223de17111c7a"
    }
  },
  {
    "ts": null,
    "headline": "Organon Appoints Joseph Morrissey as Interim CEO After Investigation Finds Possible Sales Practice Irregularities",
    "summary": "Organon (OGN) said Monday its board has appointed the company's head of manufacturing and supply Jos",
    "url": "https://finnhub.io/api/news?id=5b657a219ab8d9e087254a24ef4702074ae27086ca3f99322c5cd2bb19b51792",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761568402,
      "headline": "Organon Appoints Joseph Morrissey as Interim CEO After Investigation Finds Possible Sales Practice Irregularities",
      "id": 137228662,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Organon (OGN) said Monday its board has appointed the company's head of manufacturing and supply Jos",
      "url": "https://finnhub.io/api/news?id=5b657a219ab8d9e087254a24ef4702074ae27086ca3f99322c5cd2bb19b51792"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Keurig Dr. Pepper stock pops as investors await Big Tech earnings from Apple, Google, and more",
    "summary": "Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finnhub.io/api/news?id=d985e4a83ea21163bb9aaabf6a7d82771e58096fa9818cb3f140429c6914a413",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761566506,
      "headline": "Earnings live: Keurig Dr. Pepper stock pops as investors await Big Tech earnings from Apple, Google, and more",
      "id": 137228420,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
      "url": "https://finnhub.io/api/news?id=d985e4a83ea21163bb9aaabf6a7d82771e58096fa9818cb3f140429c6914a413"
    }
  },
  {
    "ts": null,
    "headline": "Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation",
    "summary": "JERSEY CITY, N.J., October 27, 2025--Organon (NYSE: OGN) (\"Organon\" or \"the company\") today announced that its Board of Directors has appointed the Company’s Executive Vice President and Head of Manufacturing & Supply, Joseph Morrissey, Interim Chief Executive Officer. Board Chair Carrie S. Cox will also take on additional responsibilities on an interim basis as Executive Chair to support Mr. Morrissey in his new role. Director Robert Essner will assume the role of Lead Independent Director.",
    "url": "https://finnhub.io/api/news?id=eaa865f0e2b448421b138e1de22142b554507f5595052624a5840a396aa6865f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761564600,
      "headline": "Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation",
      "id": 137228448,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "JERSEY CITY, N.J., October 27, 2025--Organon (NYSE: OGN) (\"Organon\" or \"the company\") today announced that its Board of Directors has appointed the Company’s Executive Vice President and Head of Manufacturing & Supply, Joseph Morrissey, Interim Chief Executive Officer. Board Chair Carrie S. Cox will also take on additional responsibilities on an interim basis as Executive Chair to support Mr. Morrissey in his new role. Director Robert Essner will assume the role of Lead Independent Director.",
      "url": "https://finnhub.io/api/news?id=eaa865f0e2b448421b138e1de22142b554507f5595052624a5840a396aa6865f"
    }
  },
  {
    "ts": null,
    "headline": "U.S. FDA Approves Updated Indication for WINREVAIR™ (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Based on Phase 3 ZENITH Study",
    "summary": "RAHWAY, N.J., October 27, 2025--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for WINREVAIR™ (sotatercept-csrk) for injection, 45mg, 60mg. WINREVAIR, an activin signaling inhibitor, is now FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise",
    "url": "https://finnhub.io/api/news?id=f093f76aeaf35c0a7262f9a392d55edd8a013404ecfcea993d6a9988561702cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761561900,
      "headline": "U.S. FDA Approves Updated Indication for WINREVAIR™ (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Based on Phase 3 ZENITH Study",
      "id": 137228665,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., October 27, 2025--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for WINREVAIR™ (sotatercept-csrk) for injection, 45mg, 60mg. WINREVAIR, an activin signaling inhibitor, is now FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise",
      "url": "https://finnhub.io/api/news?id=f093f76aeaf35c0a7262f9a392d55edd8a013404ecfcea993d6a9988561702cf"
    }
  },
  {
    "ts": null,
    "headline": "Merck's Winrevair gets expanded indication in US",
    "summary": "Merck has announced that the US FDA has approved an update to the label for Winrevair, an activin signaling inhibitor, based on the Phase 3 ZENITH trial in the treatment of pulmonary arterial...",
    "url": "https://finnhub.io/api/news?id=915ddafd4e767b7316544d2f50af9c76d8d746eb6963d06b2c02d7475421d22f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761556996,
      "headline": "Merck's Winrevair gets expanded indication in US",
      "id": 137227869,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck has announced that the US FDA has approved an update to the label for Winrevair, an activin signaling inhibitor, based on the Phase 3 ZENITH trial in the treatment of pulmonary arterial...",
      "url": "https://finnhub.io/api/news?id=915ddafd4e767b7316544d2f50af9c76d8d746eb6963d06b2c02d7475421d22f"
    }
  },
  {
    "ts": null,
    "headline": "Merck’s oncology prospects could portend a post-Keytruda future",
    "summary": "Can the pharma giant offset potential losses from its megablockbuster with a strong suite of contenders?",
    "url": "https://finnhub.io/api/news?id=014d761b91b18dec4df3fb487175576a60384ea504bbe1248c31fce9ae6c27c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761552000,
      "headline": "Merck’s oncology prospects could portend a post-Keytruda future",
      "id": 137228666,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Can the pharma giant offset potential losses from its megablockbuster with a strong suite of contenders?",
      "url": "https://finnhub.io/api/news?id=014d761b91b18dec4df3fb487175576a60384ea504bbe1248c31fce9ae6c27c7"
    }
  }
]